J&J announces 22 partnerships

The Johnson & Johnson Innovation unit of Johnson & Johnson (NYSE:JNJ) unveiled 22 new collaborations spanning the cancer, diabetes, rare diseases and consumer healthcare sectors. The Innovation unit also said it will start an external collaboration program to accelerate

Read the full 391 word article

How to gain access

Continue reading with a
two-week free trial.